1. 816 Evaluating the potential of harnessing anti-leukemia T cells for the treatment of T cell acute lymphoblastic leukemias (T-ALL). (10th December 2020) Authors: Triplett, Todd; Church, Sarah; Hether, Tyler; Rios, Joshua; Kottapalli, Srividya; Holay, Nisha Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 816 Evaluating the potential of harnessing anti-leukemia T cells for the treatment of T cell acute lymphoblastic leukemias (T-ALL). (9th November 2020) Authors: Triplett, Todd; Church, Sarah; Hether, Tyler; Rios, Joshua; Kottapalli, Srividya; Holay, Nisha Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 821 Class specific HDAC inhibition differentially affects the function of specific T cell subsets. (10th December 2020) Authors: Holay, Nisha; Giri, Uma; Berg, Carla Van Den; Eckhardt, Gail; Triplett, Todd Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 821 Class specific HDAC inhibition differentially affects the function of specific T cell subsets. (9th November 2020) Authors: Holay, Nisha; Giri, Uma; Berg, Carla Van Den; Eckhardt, Gail; Triplett, Todd Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors. (7th November 2013) Authors: Akporiaye, Emmanuel T; Tucker, Christopher; Triplett, Todd; Garrison, Kendra; Sun, Lihong; Ling, Leona; Weinberg, Andrew Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗